
An Alpine, NJ-based pharmaceutical executive, John Klein has served as chairman of Cambridge Therapeutics since 2011. John Klein concurrently serves as chairman and CEO of the New Jersey enterprise performance management (EPM) firm Bi-Logix, LLC, which leverages proprietary methodology to help businesses enhance decision-making processes.

Guiding Cambridge Therapeutics, John Klein is an established presence in the Alpine, New Jersey entrepreneurial community who has set in place innovative physician dispensing and drug development strategies. …

A business leader in Alpine, NJ, John Klein serves as the chairman and CEO of Cambridge Therapeutics, where he emphasizes a next-generation approach to the development of new drugs. With experience leading Cambridge Therapeutics, John Klein recently launched Bilogix, a New Jersey company that provides enterprise performance management (EPM) solutions.
…